Inland Peptides
Inland Peptides

Epitalon

Research Snapshot Last reviewed October 2026
No

Approved by the FDA for human use

Limited

Studied in human clinical trials

Limited

Published human research

Yes

Published animal research

Primary research areas
  • Aging and telomere studies

View in catalog →

Overview

Epitalon is a synthetic peptide made of four amino acids, developed in Russia for aging research. It is based on work involving epithalamin, an extract of the pineal gland, which produces melatonin.

Epitalon is not approved by the Food and Drug Administration for human use, and no prescription version exists. It should only be used within an approved clinical study and never taken without a doctor’s authorization.

What is it being studied for?

Research on Epitalon is focused on aging, telomere length, and sleep and hormone rhythms.

Telomeres protect the ends of chromosomes and usually shorten as cells divide. In human cells grown in a laboratory, Epitalon increased telomere length.

What has research found?

Animal studies have examined Epitalon’s effects on aging, including antioxidant activity in rat brain tissue.

An early human report described improved retinal function in people with retinitis pigmentosa, an inherited eye disease. Much of the older aging literature concerns epithalamin, a gland extract, rather than Epitalon.

Human studies have not established Epitalon’s long-term benefits or side effects.

FDA status and development history

Epitalon was developed through research at the Institute of Bioregulation and Gerontology in St. Petersburg. It is not FDA-approved for human use.